DERACE L SCHAFFER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DERACE L SCHAFFER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DERACE L SCHAFFER. DERACE L SCHAFFER is Chairman in CAREGUIDE INC ($PATY) and Director in PHARMATHENE, INC ($PIP) and Director in Lantheus Holdings, Inc. ($LNTH).
Latest Insider Trading Transactions of DERACE L SCHAFFER
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALT, PATY, LNTH
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 05 2020 | LNTH | Lantheus Holdings, ... | SCHAFFER DERACE L | Director | Grant | A | 0.00 | 8,095 | 0 | 25,089 | 17 K to 25.1 K (+47.63 %) |
| Jun 07 2019 | LNTH | Lantheus Holdings, ... | SCHAFFER DERACE L | Director | Sell | S | 24.71 | 10,000 | 247,127 | 16,994 | 27 K to 17 K (-37.05 %) |
| Jun 05 2019 | LNTH | Lantheus Holdings, ... | SCHAFFER DERACE L | Director | Sell | S | 24.61 | 1,080 | 26,578 | 26,994 | 28.1 K to 27 K (-3.85 %) |
| Jun 05 2019 | LNTH | Lantheus Holdings, ... | SCHAFFER DERACE L | Director | Sell | S | 24.11 | 8,920 | 215,081 | 28,074 | 37 K to 28.1 K (-24.11 %) |
| Jun 05 2019 | LNTH | Lantheus Holdings, ... | SCHAFFER DERACE L | Director | Sell | S | 23.47 | 10,000 | 234,725 | 36,994 | 47 K to 37 K (-21.28 %) |
| Apr 03 2019 | LNTH | Lantheus Holdings, ... | SCHAFFER DERACE L | Director | Sell | S | 24.41 | 10,000 | 244,094 | 46,994 | 57 K to 47 K (-17.55 %) |
| Feb 28 2019 | LNTH | Lantheus Holdings, ... | SCHAFFER DERACE L | Director | Grant | A | 0.00 | 5,353 | 0 | 56,994 | 51.6 K to 57 K (+10.37 %) |
| Mar 07 2018 | LNTH | Lantheus Holdings, ... | SCHAFFER DERACE L | Director | Grant | A | 0.00 | 7,911 | 0 | 51,641 | 43.7 K to 51.6 K (+18.09 %) |
| Jan 02 2018 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 1.93 | 38,699 | 74,778 | 589,453 | 550.8 K to 589.5 K (+7.03 %) |
| Jan 02 2018 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 1.92 | 58,711 | 112,672 | 550,754 | 492 K to 550.8 K (+11.93 %) |
| Dec 27 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 1.77 | 27,706 | 49,040 | 492,043 | 464.3 K to 492 K (+5.97 %) |
| Dec 27 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 1.76 | 50,000 | 88,170 | 464,337 | 414.3 K to 464.3 K (+12.07 %) |
| Dec 27 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 1.81 | 51,442 | 93,269 | 414,337 | 362.9 K to 414.3 K (+14.18 %) |
| Dec 27 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 1.61 | 17,982 | 28,877 | 362,895 | 344.9 K to 362.9 K (+5.21 %) |
| Dec 08 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 1.74 | 7,639 | 13,308 | 344,913 | 337.3 K to 344.9 K (+2.26 %) |
| Dec 08 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 1.80 | 16,106 | 28,996 | 337,274 | 321.2 K to 337.3 K (+5.01 %) |
| Dec 05 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 1.78 | 13,495 | 23,987 | 321,168 | 307.7 K to 321.2 K (+4.39 %) |
| Dec 05 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 1.81 | 7,300 | 13,195 | 307,673 | 300.4 K to 307.7 K (+2.43 %) |
| Dec 05 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 1.80 | 5,215 | 9,405 | 300,373 | 295.2 K to 300.4 K (+1.77 %) |
| Nov 30 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 1.84 | 12,978 | 23,816 | 295,158 | 282.2 K to 295.2 K (+4.60 %) |
| Nov 30 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 1.94 | 7,942 | 15,377 | 282,180 | 274.2 K to 282.2 K (+2.90 %) |
| Nov 30 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 1.97 | 12,395 | 24,445 | 274,238 | 261.8 K to 274.2 K (+4.73 %) |
| Nov 27 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 2.00 | 10,042 | 20,060 | 261,843 | 251.8 K to 261.8 K (+3.99 %) |
| Nov 27 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 2.02 | 6,505 | 13,162 | 251,801 | 245.3 K to 251.8 K (+2.65 %) |
| Nov 27 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 2.10 | 5,261 | 11,061 | 245,296 | 240 K to 245.3 K (+2.19 %) |
| Nov 21 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 2.06 | 7,236 | 14,905 | 240,035 | 232.8 K to 240 K (+3.11 %) |
| Nov 21 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 2.07 | 4,800 | 9,958 | 232,799 | 228 K to 232.8 K (+2.11 %) |
| Nov 21 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 2.12 | 6,295 | 13,352 | 227,999 | 221.7 K to 228 K (+2.84 %) |
| Oct 17 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Option Exercise | A | 2.50 | 20,000 | 50,000 | 20,000 | |
| Sep 14 2017 | LNTH | Lantheus Holdings, ... | SCHAFFER DERACE L | Director | Sell | S | 17.50 | 5,000 | 87,500 | 43,730 | 48.7 K to 43.7 K (-10.26 %) |
| Sep 14 2017 | LNTH | Lantheus Holdings, ... | SCHAFFER DERACE L | Director | Sell | S | 17.50 | 10,000 | 175,000 | 48,730 | 58.7 K to 48.7 K (-17.03 %) |
| Aug 28 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 2.25 | 50,000 | 112,390 | 221,704 | 171.7 K to 221.7 K (+29.12 %) |
| Aug 28 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 2.24 | 17,326 | 38,892 | 171,704 | 154.4 K to 171.7 K (+11.22 %) |
| Aug 23 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 2.22 | 43,352 | 96,350 | 154,378 | 111 K to 154.4 K (+39.05 %) |
| Aug 23 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 2.10 | 5,958 | 12,519 | 111,026 | 105.1 K to 111 K (+5.67 %) |
| Aug 23 2017 | PIP | Altimmune, Inc. | SCHAFFER DERACE L | Director | Buy | P | 2.02 | 690 | 1,395 | 105,068 | 104.4 K to 105.1 K (+0.66 %) |
| May 16 2017 | LNTH | Lantheus Holdings, ... | SCHAFFER DERACE L | Director | Sell | S | 16.55 | 5,000 | 82,750 | 58,730 | 63.7 K to 58.7 K (-7.85 %) |
| May 12 2017 | LNTH | Lantheus Holdings, ... | SCHAFFER DERACE L | Director | Sell | S | 15.75 | 10,000 | 157,500 | 63,730 | 73.7 K to 63.7 K (-13.56 %) |
| May 10 2017 | LNTH | Lantheus Holdings, ... | SCHAFFER DERACE L | Director | Sell | S | 14.75 | 10,000 | 147,500 | 73,730 | 83.7 K to 73.7 K (-11.94 %) |
| Mar 01 2017 | LNTH | Lantheus Holdings, ... | SCHAFFER DERACE L | Director | Grant | A | 0.00 | 8,730 | 0 | 83,730 | 75 K to 83.7 K (+11.64 %) |
| Jan 17 2017 | PIP | PHARMATHENE, INC | SCHAFFER DERACE L | Director | Option Exercise | M | 2.20 | 20,000 | 44,000 | 0 | |
| Jan 17 2017 | PIP | PHARMATHENE, INC | SCHAFFER DERACE L | Director | Buy | M | 2.20 | 20,000 | 44,000 | 1,043,782 | 1 M to 1 M (+1.95 %) |
| Oct 04 2016 | PIP | PHARMATHENE, INC | SCHAFFER DERACE L | Director | Option Exercise | M | 1.69 | 20,000 | 33,800 | 0 | |
| Oct 04 2016 | PIP | PHARMATHENE, INC | SCHAFFER DERACE L | Director | Option Exercise | M | 1.51 | 20,000 | 30,200 | 0 | |
| Oct 04 2016 | PIP | PHARMATHENE, INC | SCHAFFER DERACE L | Director | Option Exercise | M | 1.64 | 20,000 | 32,800 | 0 | |
| Oct 04 2016 | PIP | PHARMATHENE, INC | SCHAFFER DERACE L | Director | Option Exercise | M | 1.45 | 20,000 | 29,000 | 0 | |
| Oct 04 2016 | PIP | PHARMATHENE, INC | SCHAFFER DERACE L | Director | Option Exercise | M | 1.60 | 20,000 | 32,000 | 0 | |
| Oct 04 2016 | PIP | PHARMATHENE, INC | SCHAFFER DERACE L | Director | Option Exercise | M | 2.47 | 20,000 | 49,400 | 0 | |
| Oct 04 2016 | PIP | PHARMATHENE, INC | SCHAFFER DERACE L | Director | Option Exercise | M | 2.59 | 10,000 | 25,900 | 0 | |
| Oct 04 2016 | PIP | PHARMATHENE, INC | SCHAFFER DERACE L | Director | Buy | M | 1.69 | 20,000 | 33,800 | 1,023,782 | 1 M to 1 M (+1.99 %) |
| Oct 04 2016 | PIP | PHARMATHENE, INC | SCHAFFER DERACE L | Director | Buy | M | 1.51 | 20,000 | 30,200 | 1,003,782 | 983.8 K to 1 M (+2.03 %) |
| Oct 04 2016 | PIP | PHARMATHENE, INC | SCHAFFER DERACE L | Director | Buy | M | 1.64 | 20,000 | 32,800 | 983,782 | 963.8 K to 983.8 K (+2.08 %) |
| Oct 04 2016 | PIP | PHARMATHENE, INC | SCHAFFER DERACE L | Director | Buy | M | 1.45 | 20,000 | 29,000 | 963,782 | 943.8 K to 963.8 K (+2.12 %) |
| Oct 04 2016 | PIP | PHARMATHENE, INC | SCHAFFER DERACE L | Director | Buy | M | 1.60 | 20,000 | 32,000 | 943,782 | 923.8 K to 943.8 K (+2.17 %) |
| Oct 04 2016 | PIP | PHARMATHENE, INC | SCHAFFER DERACE L | Director | Buy | M | 2.47 | 20,000 | 49,400 | 923,782 | 903.8 K to 923.8 K (+2.21 %) |
| Oct 04 2016 | PIP | PHARMATHENE, INC | SCHAFFER DERACE L | Director | Buy | M | 2.59 | 10,000 | 25,900 | 903,782 | 893.8 K to 903.8 K (+1.12 %) |
| Jun 03 2016 | PIP | PHARMATHENE, INC | SCHAFFER DERACE L | Director | Option Exercise | A | 2.20 | 20,000 | 44,000 | 20,000 | |
| Mar 08 2016 | LNTH | Lantheus Holdings, ... | SCHAFFER DERACE L | Director | Grant | A | 0.00 | 25,000 | 0 | 75,000 | 50 K to 75 K (+50.00 %) |
| Aug 04 2015 | PIP | PHARMATHENE, INC | SCHAFFER DERACE L | Director | Option Exercise | A | 1.69 | 20,000 | 33,800 | 20,000 | |
| Feb 09 2004 | PATY | CAREGUIDE INC | SCHAFFER DERACE L | Chairman | Option Exercise | C | 10.00 | 5,318 | 53,180 | 5,318 | |
| Feb 09 2004 | PATY | CAREGUIDE INC | SCHAFFER DERACE L | Chairman | Buy | C | 0.14 | 239,882 | 33,583 | 403,490 | 163.6 K to 403.5 K (+146.62 %) |
Page: 1